Adial Pharmaceuticals Inc (NASDAQ:ADIL)
| 0.3652 Delayed Data As of 3:40pm ET |  -0.0147 / -3.87%Today’s Change | 0.20 Today|||52-Week Range 2.27 | +69.86% Year-to-Date |
Latest ADIL News | Press Releases
No recent news for Adial Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.38 |
| Today’s open | 0.36 |
| Day’s range | 0.36 - 0.38 |
| Volume | 500 |
| Average volume (3 months) | 547,335 |
| Market cap | $5.4M |
Data as of 3:40pm ET, 03/28/2023
Growth & Valuation
| Earnings growth (last year) | -19.55% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.10 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PLXPPLx Pharma Inc | -0.01 | -4.92% |
| QLGNQualigen Therapeutic... | 0.00 | 0.00% |
| ---- | ||
| ---- |
Data as of 3:58pm ET, 03/28/2023
Financials
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$19.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Charlottesville, Virginia |
Forecasts
